Genomtec (FRA:4VI) Notes Receivable: €0.00 Mil (As of Mar. 2026)


FRA:4VI Genomtec SA FRA:4VI
32 GF Score
Price €0.98
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Genomtec Notes Receivable?

Genomtec FRA:4VI -0.31% 32 Notes Receivable is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:4VI with a GF Score™ of 32/100 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Genomtec's Notes Receivable for the quarter that ended in Mar. 2026 was €0.00 Mil.

Genomtec Notes Receivable Historical Data

* Premium members only.

The historical data trend for Genomtec's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomtec Notes Receivable Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Genomtec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:4VI
32GF Score
Genomtec SA FRA:4VI
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomtec Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
Genomtec (FRA:4VI) has a Notes Receivable of €0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genomtec and its competitors.
Is Genomtec's Notes Receivable too high?
Genomtec's current Notes Receivable is €0.00 Mil. Overall, Genomtec has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Genomtec's Notes Receivable compare to ABT and SYK?
Genomtec's Notes Receivable of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genomtec and its competitors. Genomtec's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomtec stock overvalued right now?
Based on GuruFocus' analysis, Genomtec (FRA:4VI) is currently considered Significantly Overvalued. The current Notes Receivable is €0.00 Mil. Genomtec's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Genomtec (FRA:4VI), the current Notes Receivable is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genomtec Business Description

Other Exchanges GMT:Poland
Address ul. Stablowicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
32GF Score

Get the complete analysis for FRA:4VI

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.98
Price